Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pelttari

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Clinical Genetics|August 13, 2017
Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplicationL M Pelttari, H Shimelis, H Toiminen, et al.
International Journal of Cancer|March 31, 2019
Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patientsAnna Nurmi, Taru A Muranen, Liisa M Pelttari, et al.
Journal of Medical Genetics|June 2, 2012
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancerLiisa M Pelttari, Johanna Kiiski, Riikka Nurminen, et al.
Scientific Reports|November 30, 2023
NTHL1 is a recessive cancer susceptibility geneAnna K Nurmi, Liisa M Pelttari, Johanna I Kiiski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2013
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer riskVirpi H Laitinen, Tiina Wahlfors, Leena Saaristo, et al.
International Journal of Cancer|August 21, 2016
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcomeJohanna I Kiiski, Rainer Fagerholm, Anna Tervasmäki, et al.
Breast Cancer Research and Treatment|July 14, 2017
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish populationJohanna I Kiiski, Anna Tervasmäki, Liisa M Pelttari, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerJohanna I Kiiski, Liisa M Pelttari, Sofia Khan, et al.
British Journal of Cancer|November 8, 2012
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancerK Kämpjärvi, N Mäkinen, O Kilpivaara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerFergus J Couch, Steven N Hart, Priyanka Sharma, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Clinical Genetics|August 13, 2017
Gene-panel testing of breast and ovarian cancer patients identifies a recurrent RAD51C duplicationL M Pelttari, H Shimelis, H Toiminen, et al.
International Journal of Cancer|March 31, 2019
Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patientsAnna Nurmi, Taru A Muranen, Liisa M Pelttari, et al.
Journal of Medical Genetics|June 2, 2012
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancerLiisa M Pelttari, Johanna Kiiski, Riikka Nurminen, et al.
Scientific Reports|November 30, 2023
NTHL1 is a recessive cancer susceptibility geneAnna K Nurmi, Liisa M Pelttari, Johanna I Kiiski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2013
HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer riskVirpi H Laitinen, Tiina Wahlfors, Leena Saaristo, et al.
International Journal of Cancer|August 21, 2016
FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcomeJohanna I Kiiski, Rainer Fagerholm, Anna Tervasmäki, et al.
Breast Cancer Research and Treatment|July 14, 2017
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish populationJohanna I Kiiski, Anna Tervasmäki, Liisa M Pelttari, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancerJohanna I Kiiski, Liisa M Pelttari, Sofia Khan, et al.
British Journal of Cancer|November 8, 2012
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancerK Kämpjärvi, N Mäkinen, O Kilpivaara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancerFergus J Couch, Steven N Hart, Priyanka Sharma, et al.
Pageof 5